Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

January 13, 2026 - PRESSADVANTAGE - In the highly regulated field of medical device labeling translation, ensuring that ...

EMA and FDA have jointly issued guiding principles for the safe and responsible use of AI across the medicines life cycle, aiming to harmonize ...

Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has reached a licensing ...

The UK Health Security Agency (UKHSA) has issued advice following the spread of a deadly virus with no cure and no vaccine.

Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for ...

At 31 October 2025, net liabilities of the Group amounted to £8.4 million (30 April 2025: £3.8 million) and it held cash of £8.6 million (30 April 2025: £16.9 million). R&D tax credits of £3.0 million ...

Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody and Moditope active immunotherapies to treat cancer, today announces a business ...

Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives January 28, 2026 4:00 PM ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced the appointment of ...